Tryptamine Therapeutics (ASX:TYP) has provided further data from its recently completed phase 1b study utilising TRP-8803, with all key objectives met including: TRP-8803 safe at low, mid, and upper ...
Tryptamine Therapeutics has reached a milestone in development of its novel IV-infused psilocin formulation TRP-8803, with the drug meeting all phase 1b study objectives. Tryptamine Therapeutics ...
(RTTNews) - Cytokinetics (CYTK) presented data from the Phase 1 study of CK-4021586, or CK-586. The study met its primary and secondary objectives to assess the safety, tolerability and ...
Ventyx Biosciences disclosed positive top-line results from its Phase 2a study of VTX3232 in patients with early-stage Parkinson's disease. The clinical-stage biotech company said the study ...
Tenable Inc, the Exposure Management company, has published a new study revealing that 73% of organisations in India plan to harness generative AI (GenAI) within the next 12 months to enhance security ...
Negative parental involvement in Go Games activities requires better communication to get across the principles of the modified format for underage that the GAA has developed and has in place since ...
Nearly 300,000 lives could be saved from the nation’s wave of gun violence over the next decade if every US state enacted gun control laws like those held by states such as California and New York, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback